Abdullahi, Isahaq2010-11-022010-11-022010-11-02https://hdl.handle.net/11299/96002The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.Implanon (single-rod, progesterone only, non-biodegradable implant) is an effective hormonal alternative with tolerable side effects for premenopausal women suffering from chronic pelvic pain secondary to pelvic congestion syndrome. Prior treatment involved transcatheter embolotherapy of the ovarian veins. Implanon was able to decrease the symptoms of chronic pelvic pain due to pelvic congestion syndrome in the experimental group. In addition, Implanon decreased venous congestion as seen by improved venography evaluations after completion of the study, It is believed that venous stasis as a result of tortuous and dilated veins in the pelvis is the underlying pathophysiology of pelvic congestion syndrome. Implanon’s side effects were reported to be much more tolerable than other hormonal therapy treatments, and a safe alternative for women who desire non-invasive treatment.en-USchronic pelvic painpelvic congestion syndrometreatmentOther